The Hugo™ RAS system is gaining prominence in the field of urologic robotic surgery. To date, no study has described robot-assisted video-endoscopic inguinal lymphadenectomy (RAVEIL) using this system.
Therefore, the aim of the study is to evaluate the feasibility and safety of the procedure, focusing on surgical set-up and preliminary results.
A total of seven procedures in five patients with penile cancer were prospectively included. Baseline patient characteristics, intra- and post-operative surgical outcomes were recorded.
Overall, four patients (80%) had negative clinical N-staging (cN0). Median (IQR) operative time was 90 (85-97.5) minutes, with a median (IQR) of 8 (8-9) lymph node yield per procedure. One post-operative complication, a lymphocele requiring percutaneous drainage (Clavien-Dindo 3a), was reported. Median (IQR) hospital stay was 3 (3-3.5) days and the median (IQR) time to drain removal was 8 (6.5-10) days.
This is the first case series demonstrating the safety and feasibility of RAVEIL using the Hugo™ RAS system. The surgical configuration described may serve as a valuable reference standard for RAVEIL with this robotic platform and help novel adopters in implementing the platform in another surgical scenario.
Minerva urology and nephrology. 2025 Feb [Epub]
Josep M Gaya, Camille Berquin, Giuseppe Basile, Alessio Pecoraro, Andrea Gallioli, Isabel Sanz Gomez, Paula Izquierdo, Angelo Territo, Pavel Gavrilov, Joan Palou, Antonio Rosales, Alberto Breda
Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain., Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain - .
PubMed http://www.ncbi.nlm.nih.gov/pubmed/40183184